Share this with FacebookShare this with TwitterShare this with LinkedInEmail this pagePrint this page
KSHB: Saint Luke's Health System doctor weighs in on remdesivir following FDA-approval
October 27, 2020
The Food and Drug Administration recently approved remdesivir, an antiviral drug, to treat some patients with COVID-19.
KSHB talked to Dr. Sarah Boyd, an infectious disease physician on Saint Luke's COVID Response Team, about when it's used and what remains to be seen with further testing.
Watch the full story below.